Navigation Links
The Time To Rethink Male Circumcision Is Now, Group Says In Launching www.intactamerica.org
Date:6/25/2009

apin was joined by pediatrician Dr. Robert Van Howe, Clinical Professor at Michigan State University's College of Human Medicine, and his wife, Dr. Michelle Storms, a family practice physician and Assistant Professor at the medical school.

"The child is the patient, not the parent, and neonatal circumcision is definitely not in the patients' best interest," said Dr. Van Howe. "As an adult, I can say yes or no based on informed consent. An infant obviously cannot do that."

Dr. Storms, who is also Research Director in the MSU Family Medicine Residency Program, stopped performing circumcisions in 1988.

"I realized I was cutting off healthy tissue from a baby that couldn't say no," said Dr. Storms. "I wasn't treating or diagnosing disease. It violated everything I was taught in medical school about my obligation to heal the sick and do no harm."

Texas businessman Dean Pisani made a $1 million commitment to Intact America after he and his wife, who did not know their children's gender before their births, were pressured by Illinois doctors to perform a circumcision if they had a son.

"My wife and I did our research and could find no rational or persuasive argument to subject a baby to surgery that had no medical benefit," said Pisani. "No doctor could substantiate the medical necessity to perform the surgery. The pressure was both inappropriate and indefensible."

Male circumcision is the most commonly performed surgery in the United States, the only industrialized nation (other than South Korea) that continues to circumcise a majority of boys for non-religious reasons.

"If circumcision were effective in preventing HIV infection, the U.S.'s high circumcision rate would yield a lower HIV rate," said Chapin. "But America's HIV rate is higher than other industrialized nations with low circumcision rates. The only reliable means of preventing se
'/>"/>

SOURCE Intact America
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. reThinking eHealth Webinar: Will the Patient Centered Medical Home Be the Model for Universal Healthcare?
2. A Different Way of Thinking for a Fulfilling Life: New Book Offers Practical Guidance for Rethinking Happiness and Nurturing Self-Love
3. Medical Experts Call on Media to Rethink Coverage of Weight Loss
4. UK and US guidelines on kids physical activity levels need rethinking
5. Surgeons Rethink Approach to Minimal Incision Foot and Ankle Surgery
6. Intact America Launches Campaign to Change How America Thinks About Male Circumcision
7. Clinical Innovations Introduces New Circumcision Device
8. Unprecedented Scale-Up of Voluntary Male Circumcision Begins in Swaziland and Zambia
9. Circumcision Guards Against STDs
10. Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched
11. Circumcision rates lower in states where Medicaid does not cover procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Stem cells that could one day provide therapeutic options ... from the tissue of the umbilical cord, just as ... to treat some blood disorders, said University of Pittsburgh ... of the Journal of Biomedicine and Biotechnology ... expanded to greater number, are remarkably stable and might ...
(Date:12/17/2009)... urge screening within year of first intercourse , , THURSDAY, ... in U.S. cities, about half acquire at least one ... or trichomoniasis -- within two years of becoming sexually ... of 381 girls, aged 14 to 17, also found ... repeated infections. , "Depending on the organism, within four ...
(Date:12/17/2009)... of nimotuzumab , ... (PRWEB) ... Therapure Biopharma Inc. and David Allan, Chairman and CEO of ... under which Therapure Biopharma will provide aseptic fill and finish ... majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of ...
(Date:12/17/2009)... - Procedure Provides Efficient Mechanism to Pursue ... QC, Dec. 17 /PRNewswire-FirstCall/ - Labopharm Inc. ... announced it has initiated the regulatory approval ... Europe under the Decentralized Procedure (DCP). The ... a company to simultaneously pursue regulatory approval ...
(Date:12/17/2009)... HOUSTON, Dec. 17 John Howell, ... subsidiary of Arrayit Corporation (OTC Bulletin Board: ... timeline for commercialization of its microarray-based ... which is currently advancing through late-stage development ... assigned exclusively to the Company by Arrayit ...
Breaking Medicine News(10 mins):Health News:Umbilical cord could be new source of plentiful stem cells, say Pitt researchers 2Health News:STDs Common Among Sexually Active Teen Girls in Cities 2Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 2Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 3Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 4Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 2Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 3Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 3Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 4
... Pharmacists Association (NCPA) is endorsing Sen. Mark Pryor,(D-AR), ... the,U.S. Senate. Bruce Roberts, RPh, executive vice president ... "Senator Mark Pryor is a powerful advocate for ... serve. That is why the National,Community Pharmacists Association ...
... Oct. 8 The National,Community Pharmacists Association (NCPA) ... representing Montana, for re-election to the,U.S. Senate. Bruce ... NCPA,issued the following statement:, "Senator Max Baucus ... pharmacies and the patients they serve. That is ...
... Pharmacists Association (NCPA) is endorsing Sen. Gordon Smith,(R-OR), ... the,U.S. Senate. Bruce Roberts, RPh, executive vice president ... "Senator Gordon Smith is a powerful advocate for ... serve. That is why the National,Community Pharmacists Association ...
... A normal reaction to stressful events or something more? ... BOSTON, Oct. 8 With the crisis on ... and food prices,throughout the country, no one can blame ... common and understandable to be angry,worried and even gloomy, ...
... offers Limited-Edition ... Breast Cancer Research, ST. LOUIS, Oct. 8 Whether it,s ... known to comfort,their owners. This soothing role can be especially important ... support of all women,battling cancer and those who are survivors, Purina(R) ...
... Moog Inc. (NYSE:,MOG.A and MOG.B) announced today ... brand name. The organizations and product lines will ... product portfolio within a,single, well-established company., "While ... associated with the,products, this event joins three companies ...
Other Medicine News:Health News:Economic Crisis Making You Anxious or Depressed? 2Health News:Economic Crisis Making You Anxious or Depressed? 3Health News:Purina(R) Cat Chow(R) Brand Cat Food Partners With Susan G. Komen for the Cure(R) 2Health News:Purina(R) Cat Chow(R) Brand Cat Food Partners With Susan G. Komen for the Cure(R) 3
(Date:12/17/2009)... Dec, 17 Connectyx Technologies Holding Group ... has formed a distribution partnership with United States ... Diabetic Supplies, Respiratory Supplies and Medications as well ... Dysfunction System. ,, Terms of the partnership were ... that, "This partnership adds to our growing distribution ...
(Date:12/17/2009)... -- Instacare Corp. (OTC Bulletin Board: ISCR) a ... drugs and diagnostics and at home testing products ... and provider of e-health technologies and revolutionary cell ... as part of the preparation of its Fiscal ... two new Directors and has rejected, as unneeded, ...
(Date:12/17/2009)... N.C., Dec. 17 Pharmaceutical Institute today ... GeneEd, Inc., a company specializing in life science ... e-courses, help expand Pharmaceutical Institute,s already extensive library ... is a leading provider of specialized training solutions ... subsidiary of Campbell Alliance. Financial terms of ...
Breaking Medicine Technology:Connectyx Announces Distribution Partnership with United States Medical Supply 2Connectyx Announces Distribution Partnership with United States Medical Supply 3Instacare Corp. Board of Directors Sets Growth Plans for 2010 2Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 2Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 3Nanogea Announces New Scientific Advisory Board Members 14402 1Nanogea Announces New Scientific Advisory Board Members 14402 2Nanogea Announces New Scientific Advisory Board Members 14402 3Breathe Safely LLC 3A Making Respirators 270 25 More Effective 59186 1Breathe Safely LLC 3A Making Respirators 270 25 More Effective 59186 2Chews 4 Health Dietary Supplements to be Featured on 26apos 3BBeauty Spaces 26apos 3B 59181 1Chews 4 Health Dietary Supplements to be Featured on 26apos 3BBeauty Spaces 26apos 3B 59181 2Chews 4 Health Dietary Supplements to be Featured on 26apos 3BBeauty Spaces 26apos 3B 59181 3
... Fuisz Tobacco today,announces the results of a ... the use of Fuisz Tobacco,s dissolving tobacco,strip and ... -- the study,s control., (Photo: http://www.newscom.com/cgi-bin/prnh/20080115/CLTU066 ... bioavailability for the,Fuisz Tobacco strip. A Fuisz Tobacco ...
... Placebo-Controlled Study Results Published in May 20 ... May 20 Eisai Corporation of North,America ... study in,Neurology that found patients with Lennox-Gastaut ... rufinamide as adjunctive,therapy experienced more than 40% ...
Other Medicine Technology:Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product 2Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product 3Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40% 2Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40% 3